Sign Up to like & get
recommendations!
0
Published in 2019 at "Emerging Infectious Diseases"
DOI: 10.3201/eid2504.181689
Abstract: Current standard therapies for toxoplasmic encephalitis often cause severe adverse events. A 57-year-old HIV-positive man in Japan who had toxoplasmic encephalitis but was intolerant to trimethoprim/sulfamethoxazole, pyrimethamine, sulfadiazine, and atovaquone was successfully treated with the…
read more here.
Keywords:
combination;
clindamycin azithromycin;
encephalitis;
alternative treatment ... See more keywords